Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 4 Lymphoid 3 Other hematologic neoplasm 2 Thoracic 1 NET 1 Myeloid 1 Endocrine 1

Conditions

Interventions

Carboplatin 509 Cisplatin 410 Pemetrexed 399 Radiotherapy 282 Docetaxel 244 Paclitaxel 227 pembrolizumab 225 Gemcitabine 198 Drug Therapy 191 Bevacizumab 190 Erlotinib Hydrochloride 189 Radiosurgery 176 Nivolumab 168 Etoposide 155 durvalumab 154 osimertinib 126 atezolizumab 109 Gefitinib 96 Blood Specimen Collection 93 Vinorelbine 90 Magnetic Resonance Spectroscopy 90 anlotinib 88 Surgical Procedures, Operative 85 Ipilimumab 62 Immunotherapy 62 Surveys and Questionnaires 60 sintilimab 59 Specimen Handling 59 tislelizumab 58 Irinotecan 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × 68Ga-pentixafor × Thoracic × Clear all

NCT06086327 2023-10-17

Application of 68Ga-Pentixafor PET/CT for Thymoma

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡